dimethylphenylpiperazinium iodide has been researched along with Muscular Atrophy in 1 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WEIS, J | 1 |
1 other study available for dimethylphenylpiperazinium iodide and Muscular Atrophy
| Article | Year |
|---|---|
Biphasic response of guinea-pig's taenia coli induced by 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP).
Topics: Colon; Dimethylphenylpiperazinium Iodide; Ganglionic Blockers; Guinea Pigs; Iodides; Muscular Atroph | 1962 |